Dysferlin is a stress-inducible antifibrotic regulator that limits maladaptive fibroblast differentiation and myocardial fibrosis, thereby representing a potential therapeutic target to attenuate adverse cardiac remodelling in HF.
BACKGROUND
Accumulation of extracellular matrix (ECM) causes tissue fibrosis that contributes to myocardial dysfunction and heart failure (HF), yet there are no approved anti-fibrotic therapeutics that target it. Inhibitors of BET proteins (BETi) reduced fibrosis in preclinical HF models, and clinical-stage BETi, apabe...
S. Wasiak, D. Gilham, L. Fu et al.· Biomedicine & pharmacotherap...· 0 citations
AIMS
Pathological cardiac hypertrophy serves as the primary pathological driver of heart failure, significantly impacting patient prognosis. Deubiquitinating enzymes, which play pivotal roles in protein homeostasis, are emerging as key regulators in cardiac hypertrophy and dysfunction. This study sought to elucidate th...
Wei Zhao, Qi-Lin Li, Huan Zhao et al.· Life Science· 0 citations
Cardiac hypertrophy is a major pathological response to cardiovascular stress and a critical contributor to heart failure (HF). Gentiopicroside (GPS), a naturally occurring iridoid glycoside derived from Gentiana scabra, exhibits anti-inflammatory, antioxidant, and anti-fibrotic properties. However, its role and molecu...
Ming-Zhen Cao, Da Ke, Jian Ni et al.· Phytotherapy Research· 0 citations
Highlights
Sorbs2 is an adaptor and cytoskeletal protein predominantly expressed in the cardiovascular system-specifically in cardiomyocytes, vascular smooth muscle cells, and endothelial cells. It plays a critical role in maintaining myocardial structural integrity, regulating contractility, and facil...
A. Atoyan, Margarita A. Zholkovskaya, Amina A. Savlokhova et al.· Complex Issues of Cardiovasc...· 0 citations
Genetically predicted TXNDC17 expression was inversely associated with IHD risk and implicated macrophage TXNDC17 in regulating inflammatory conditioned-medium-mediated cardiomyocyte injury, although its causal relevance to IHD in vivo remains to be established.
Huan-Ze Weng, Bo Yang, Xiao-Lei Fu et al.· International Immunopharmaco...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.